Home
›
Altamira Therapeutics Ltd.
› SCHEDULE 13G/A Feb 14, 2025
Altamira Therapeutics Ltd. (CYTOF): SCHEDULE 13G/A filed Feb 14, 2025
Form type
SCHEDULE 13G/A
Filing date
Feb 14, 2025
Accession number
0001172661-25-001302
Filer
Altamira Therapeutics Ltd.
(CIK 1601936)